Sante et Prevoyance

Research site

Belgium Rue Saint-Luc 8, 5004 Namur, Belgium

3 trials recruiting
Coronary artery disease · Adenocarcinoma pancreas · Chronic hepatitis B
Adult patients

About Specializations

Sante et Prevoyance in Namur, Belgium specialises in clinical trials of conditions such as Coronary artery disease, Adenocarcinoma pancreas, Chronic hepatitis B, Colon cancer stage II, and other specialisations. This site conducts important research.

Main research areas of the site

Hepatology

The medical center is at the forefront of hepatology, focusing on the treatment and management of liver diseases. The center's research is particularly concentrated on chronic hepatitis B infections, exploring innovative therapeutic strategies to improve patient outcomes.

Chronic Hepatitis B Management
Viral Hepatitis Research
Liver Disease Prevention

By investigating the role of ethnicity in treatment responses, the center contributes significantly to personalized medicine approaches in hepatology, enhancing the understanding of how genetic and demographic factors influence disease progression and treatment efficacy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Rue Saint-Luc 85004 NamurBelgium

Open in maps ↗

Recruiting now: 3 trials
Conditions studied: 8

More sites in Namur Belgium

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

6 clinical trials

Metabolic dysfunction-associated steatohepatitis+1

Recruiting

A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

Investigational

A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:BI 456906
Sponsor:Boehringer Ingelheim International GmbH

Contact Research Centre

Coronary artery disease

Recruiting

Study on Colchicine for Patients with Coronary Artery Disease After Percutaneous Coronary Intervention

Registered drug

Study on Colchicine for Patients with Coronary Artery Disease After Percutaneous Coronary Intervention

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Colchicine
Sponsor:Az St-Jan Brugge-Oostende A.V.

Contact Research Centre

Adenocarcinoma pancreas

Recruiting

Study on Preoperative Treatment with mFOLFIRINOX or Gemcitabine-Paclitaxel for Patients with Borderline Resectable Pancreatic Cancer

Registered drugNo placebo

Study on Preoperative Treatment with mFOLFIRINOX or Gemcitabine-Paclitaxel for Patients with Borderline Resectable Pancreatic Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Hopital Erasme

Contact Research Centre

Coronary artery disease+1

Not yet recruiting

Oral versus intravenous tranexamic acid to reduce bleeding in patients undergoing off‑pump coronary artery bypass surgery

Registered drugNo placebo

Oral versus intravenous tranexamic acid to reduce bleeding in patients undergoing off‑pump coronary artery bypass surgery

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Tranexamic Acid

Contact Research Centre

Chronic hepatitis B

Not recruiting

Study on Stopping Tenofovir Alafenamide, Tenofovir Disoproxil, and Entecavir in Patients with Chronic Hepatitis B

Registered drugNo placebo

Study on Stopping Tenofovir Alafenamide, Tenofovir Disoproxil, and Entecavir in Patients with Chronic Hepatitis B

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Entecavir
Sponsor:Antwerp University Hospital

Contact Research Centre

Colon cancer stage III+1

Not recruiting

Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Resected Colon Cancer

Registered drug

Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Resected Colon Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Antwerp University Hospital

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites